Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy

We evaluated biomarkers related to kidney fibrosis for the outcome of patients with IgA nephropathy (IgAN). Clinical parameters (estimated glomerular filtration rate, hypertension, proteinuria) and histological findings were assessed in 134 patients with IgAN at the time of diagnosis and followed up...

Full description

Bibliographic Details
Main Authors: Michaela Neprasova, Dita Maixnerova, Nadja Sparding, Federica Genovese, Morten Asser Karsdal, Helena Koprivova, Marek Kollar, Miloslav Suchanek, Zdenka Hruskova, Vladimir Tesar
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/3/2064
_version_ 1797624493868318720
author Michaela Neprasova
Dita Maixnerova
Nadja Sparding
Federica Genovese
Morten Asser Karsdal
Helena Koprivova
Marek Kollar
Miloslav Suchanek
Zdenka Hruskova
Vladimir Tesar
author_facet Michaela Neprasova
Dita Maixnerova
Nadja Sparding
Federica Genovese
Morten Asser Karsdal
Helena Koprivova
Marek Kollar
Miloslav Suchanek
Zdenka Hruskova
Vladimir Tesar
author_sort Michaela Neprasova
collection DOAJ
description We evaluated biomarkers related to kidney fibrosis for the outcome of patients with IgA nephropathy (IgAN). Clinical parameters (estimated glomerular filtration rate, hypertension, proteinuria) and histological findings were assessed in 134 patients with IgAN at the time of diagnosis and followed up prospectively (mean follow-up time, 56.5 months). We measured biomarkers of collagen and laminin turnover in serum and urine collected at the time of kidney biopsy using a novel enzyme-linked immunosorbent assay. Linear discriminant analysis and logistic regression models were used to predict the patient’s kidney outcome. Five serum and urine biomarkers of laminin and collagen turnover (sLG1M, sPRO-C3, sPRO-C6, uPRO-C6/Cr, uC3M/Cr) could significantly differentiae IgAN patients with a worse prognosis. Clinical parameters (glomerular filtration rate (GFR), proteinuria) distinguished patients at risk of IgAN progression with a specificity of 87.3% and a sensitivity of 45.2% (area under the curve-AUC 0.751). The addition of the biomarkers significantly increased the prognostic ability with a specificity of 85.1% and a sensitivity of 73.3% (AUC 0.905). We have identified three serum (sLG1M, sPRO-C3, sPRO-C6) and two urinary markers (uPRO-C6/Cr, u-C3M /Cr) that significantly improve the prognostic ability of markers of kidney function to identify an IgAN patient’s risk of progressing to ESKD.
first_indexed 2024-03-11T09:43:08Z
format Article
id doaj.art-beb1bd4dd08e4bf4a501d4752905aca1
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T09:43:08Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-beb1bd4dd08e4bf4a501d4752905aca12023-11-16T16:51:48ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-01243206410.3390/ijms24032064Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA NephropathyMichaela Neprasova0Dita Maixnerova1Nadja Sparding2Federica Genovese3Morten Asser Karsdal4Helena Koprivova5Marek Kollar6Miloslav Suchanek7Zdenka Hruskova8Vladimir Tesar9Department of Nephrology, 1st Faculty of Medicine and General University Hospital, Charles University, 128 08 Prague, Czech RepublicDepartment of Nephrology, 1st Faculty of Medicine and General University Hospital, Charles University, 128 08 Prague, Czech RepublicNordic Bioscience, 2730 Herlev, DenmarkNordic Bioscience, 2730 Herlev, DenmarkNordic Bioscience, 2730 Herlev, DenmarkInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine and General University Hospital, Charles University, 128 08 Prague, Czech RepublicDepartment of Clinical and Transplant Pathology, Institute of Clinical and Experimental Medicine, 140 21 Prague, Czech RepublicConsultant of Chemometrics, 140 00 Prague, Czech RepublicDepartment of Nephrology, 1st Faculty of Medicine and General University Hospital, Charles University, 128 08 Prague, Czech RepublicDepartment of Nephrology, 1st Faculty of Medicine and General University Hospital, Charles University, 128 08 Prague, Czech RepublicWe evaluated biomarkers related to kidney fibrosis for the outcome of patients with IgA nephropathy (IgAN). Clinical parameters (estimated glomerular filtration rate, hypertension, proteinuria) and histological findings were assessed in 134 patients with IgAN at the time of diagnosis and followed up prospectively (mean follow-up time, 56.5 months). We measured biomarkers of collagen and laminin turnover in serum and urine collected at the time of kidney biopsy using a novel enzyme-linked immunosorbent assay. Linear discriminant analysis and logistic regression models were used to predict the patient’s kidney outcome. Five serum and urine biomarkers of laminin and collagen turnover (sLG1M, sPRO-C3, sPRO-C6, uPRO-C6/Cr, uC3M/Cr) could significantly differentiae IgAN patients with a worse prognosis. Clinical parameters (glomerular filtration rate (GFR), proteinuria) distinguished patients at risk of IgAN progression with a specificity of 87.3% and a sensitivity of 45.2% (area under the curve-AUC 0.751). The addition of the biomarkers significantly increased the prognostic ability with a specificity of 85.1% and a sensitivity of 73.3% (AUC 0.905). We have identified three serum (sLG1M, sPRO-C3, sPRO-C6) and two urinary markers (uPRO-C6/Cr, u-C3M /Cr) that significantly improve the prognostic ability of markers of kidney function to identify an IgAN patient’s risk of progressing to ESKD.https://www.mdpi.com/1422-0067/24/3/2064IgA nephropathybiomarkersPRO-C6PRO-C3LG1MC3M
spellingShingle Michaela Neprasova
Dita Maixnerova
Nadja Sparding
Federica Genovese
Morten Asser Karsdal
Helena Koprivova
Marek Kollar
Miloslav Suchanek
Zdenka Hruskova
Vladimir Tesar
Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
International Journal of Molecular Sciences
IgA nephropathy
biomarkers
PRO-C6
PRO-C3
LG1M
C3M
title Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
title_full Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
title_fullStr Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
title_full_unstemmed Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
title_short Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
title_sort serum and urine biomarkers related to kidney fibrosis predict kidney outcome in czech patients with iga nephropathy
topic IgA nephropathy
biomarkers
PRO-C6
PRO-C3
LG1M
C3M
url https://www.mdpi.com/1422-0067/24/3/2064
work_keys_str_mv AT michaelaneprasova serumandurinebiomarkersrelatedtokidneyfibrosispredictkidneyoutcomeinczechpatientswithiganephropathy
AT ditamaixnerova serumandurinebiomarkersrelatedtokidneyfibrosispredictkidneyoutcomeinczechpatientswithiganephropathy
AT nadjasparding serumandurinebiomarkersrelatedtokidneyfibrosispredictkidneyoutcomeinczechpatientswithiganephropathy
AT federicagenovese serumandurinebiomarkersrelatedtokidneyfibrosispredictkidneyoutcomeinczechpatientswithiganephropathy
AT mortenasserkarsdal serumandurinebiomarkersrelatedtokidneyfibrosispredictkidneyoutcomeinczechpatientswithiganephropathy
AT helenakoprivova serumandurinebiomarkersrelatedtokidneyfibrosispredictkidneyoutcomeinczechpatientswithiganephropathy
AT marekkollar serumandurinebiomarkersrelatedtokidneyfibrosispredictkidneyoutcomeinczechpatientswithiganephropathy
AT miloslavsuchanek serumandurinebiomarkersrelatedtokidneyfibrosispredictkidneyoutcomeinczechpatientswithiganephropathy
AT zdenkahruskova serumandurinebiomarkersrelatedtokidneyfibrosispredictkidneyoutcomeinczechpatientswithiganephropathy
AT vladimirtesar serumandurinebiomarkersrelatedtokidneyfibrosispredictkidneyoutcomeinczechpatientswithiganephropathy